Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Polymerase Chain Reaction × Clear all

NCT00801385 2009-08-25

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms